Increased Levels of Arginase in Patients With Acute Hepatitis B Suppress Antiviral T Cells
about
The role of myeloid cell activation and arginine metabolism in the pathogenesis of virus-induced diseasesProfiling the repertoire of T-cell receptor beta-chain variable genes in peripheral blood lymphocytes from subjects who have recovered from acute hepatitis B virus infection.Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells.Myeloid Cell Arg1 Inhibits Control of Arthritogenic Alphavirus Infection by Suppressing Antiviral T CellsHepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B.Serum arginase, a biomarker of treatment efficacy in human African trypanosomiasisMyeloid-derived suppressor cells are associated with viral persistence and downregulation of TCR ζ chain expression on CD8(+) T cells in chronic hepatitis C patients.Immunoprevalence and immunodominance of HLA-Cw*0801-restricted T cell response targeting the hepatitis B virus envelope transmembrane region.The role of natural killer cells and CD8(+) T cells in hepatitis B virus infection.Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response?Therapeutic vaccines in HBV: lessons from HCV.Immune Response in Hepatitis B Virus Infection.High-Throughput Analysis of the T Cell Receptor Beta Chain Repertoire in PBMCs from Chronic Hepatitis B Patients with HBeAg SeroconversionThe challenge of protecting without overprotecting: The two sides of myeloid-derived suppressor cells in hepatitis B viral infection.Dynamics of the Immune Response in Acute Hepatitis B Infection.Immunotherapy for Chronic Hepatitis B Virus Infection.Fasudil mediates cell therapy of EAE by immunomodulating encephalomyelitic T cells and macrophages.
P2860
Q26859106-8C67CD55-62BD-4B90-9F31-AB96AA7526F1Q33858376-B547CB3A-B84E-40DE-BF37-86C0ED212576Q35690250-C3E644FE-D469-4EB7-A37A-9951F0E202EEQ35799153-5C05BEDC-E2DC-4BC0-BF90-E0D6B659FBC9Q36614504-B01F6523-FFA5-42F6-BDAA-95362F077913Q36971133-9C1874D9-7154-496F-B096-1B58E5779E16Q37532685-D3CDE8FF-2323-4C5D-BCD0-4F984230034EQ37547521-351068F9-E37B-4ABB-ADA8-152AABE4E945Q38219409-C15729E2-681C-4E6A-9082-F1038144BA01Q38289729-23E34913-6D38-4AD5-9EB1-5E83D3634735Q38312255-AB575C36-F70C-4CA1-BE73-4F90CC3E3363Q38541811-2A6417F2-0BAB-428A-8500-1A32FC05C8DBQ40486931-904526E5-D4F5-480C-B078-CCC5D4DF391AQ40873573-8F50462C-F835-405F-A45C-DB3E79A5E1A2Q47165468-CCFCA3A6-DC8B-4756-9FDE-9E34354427BAQ47556416-7A0121B2-41E4-45C4-B355-134F58F37C0EQ48495282-A8BCED06-A724-4C6B-9693-075C2027F9D5
P2860
Increased Levels of Arginase in Patients With Acute Hepatitis B Suppress Antiviral T Cells
description
im Juli 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 April 2012
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2012
@uk
name
Increased Levels of Arginase i ...... s B Suppress Antiviral T Cells
@en
Increased Levels of Arginase i ...... s B Suppress Antiviral T Cells
@nl
type
label
Increased Levels of Arginase i ...... s B Suppress Antiviral T Cells
@en
Increased Levels of Arginase i ...... s B Suppress Antiviral T Cells
@nl
prefLabel
Increased Levels of Arginase i ...... s B Suppress Antiviral T Cells
@en
Increased Levels of Arginase i ...... s B Suppress Antiviral T Cells
@nl
P2093
P50
P1433
P1476
Increased levels of arginase i ...... s B suppress antiviral T cells
@en
P2093
Anthony Tan
Diletta Laccabue
Elena Sandalova
Ho Zi Zong
Tsunamasa Watanabe
P304
P356
10.1053/J.GASTRO.2012.03.041
P407
P577
2012-04-01T00:00:00Z